EDUCATIONAL OBJECTIVES

• Review data from clinical trials of new antiseizure medications as related to the standard of care of DS management
• Evaluate each patient’s response to antiseizure medications for prompt adjustment of therapy
• Confirm a diagnosis of DS in children presenting with symptoms or in children and adults presenting with DRE using new diagnostic approaches that include diagnostic testing
• Devise a multidisciplinary approach to DS management to address seizure- and non‐seizure‐related symptoms

Featured Speakers:Danielle Andrade, MD, MSc, FRCPC, CSCN (EEG)
Professor of Medicine (Neurology),
Medical Director, Epilepsy Program
Director of Epilepsy Genetics Research Program
Director, Epilepsy Transition Program
University of Toronto

Mary Lynn Zupanc, MD, FAAP, FAAN
Professor, Department of Pediatrics and Neurology
University of California-Irvine
CHOC-Children’s Hospital
Part of the message is hidden for the guests. Please log in or register to see it.